SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 809.06 |
| Enterprise Value ($M) | 684.95 |
| Book Value ($M) | 309.85 |
| Book Value / Share | 6.32 |
| Price / Book | 2.61 |
| NCAV ($M) | 302.21 |
| NCAV / Share | 6.17 |
| Price / NCAV | 2.68 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.99 |
| Current Ratio | 19.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 318.13 |
| Assets | 325.76 |
| Liabilities | 15.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -104.55 |
| Net Income | -89.02 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -73.19 |
| Cash from Investing | -36.00 |
| Cash from Financing | 133.16 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Polar Capital Holdings Plc | 4.89 | -11.09 | |
| 13G/A | Fairmount Funds Management LLC | 6.60 | 0.00 | |
| 13G/A | Commodore Capital Lp | 8.70 | 41.29 | |
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 8.50 | 36.26 | |
| 13G/A | Citadel Advisors Llc | 3.70 | ||
| 13G/A | Ra Capital Management, L.p. | 2.20 | ||
| 13G | BlackRock, Inc. | 6.20 | 0.00 | |
| 13D/A | 5AM Ventures VI, L.P. | 4.90 | -18.74 | |
| 13D/A | Orbimed Advisors Llc | 16.80 | -11.54 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 46,066 | 153,807 | 29.95 | |
| 57,075 | 297,949 | 19.16 | |
| 111,358 | 509,359 | 21.86 | |
| 50,180 | 538,377 | 9.32 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DSGN – Design Therapeutics, Inc. | DVAX – Dynavax Technologies Corporation |
| EDIT – Editas Medicine, Inc. | ENTA – Enanta Pharmaceuticals, Inc. |
| ERAS – Erasca, Inc. |
Financial data and stock pages provided by
Fintel.io